<<< Chapter Variants Paris is burning In Île-de-France (Greater Paris region, 12 million people), the 7-day rolling incidence per 100.000 was approaching 600 this week (Figure 1). Hospital services, both intensive and non-intensive COVID...
3 December Manna A. Be Aware of Droplets and Bubbles. Ann Intern Med 2020, published 1 December. Web page: https://doi.org/10.7326/G20-0114 No comment. 28 November Cunningham L, Nicholson PJ, O’Cnnor J, McFadden JP. Cold...
Blog 3 December WHO Solidarity Trial Consortium. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. N Engl J Med 2020, published 2 December. Full-text: https://doi.org/10.1056/NEJMoa2023184 Harrington DP, Baden LR, Hogan JW...
Blog 3 December WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation. Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them. N Engl J Med 2020, published 2...
Blog 3 December Dugdale CM, Anahtar MN, Chiosi JJ, et al. Clinical, laboratory, and radiologic characteristics of patients with initial false-negative SARS-CoV-2 nucleic acid amplification test results. Open Forum Infect Dis 2020, published 24...
Blog 1 Dezember Popa A, Genger JW, Nicholson MD. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Science Translational Medicine 23 November 2020: eabe2555. Full-text: https://doi.org/10.1126/scitranslmed.abe2555 Alexandra...
Blog 2 Dezember Agarwal V, Venkatakrishnan AJ, Puranik A et al. Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity. Cell Death Discov. 6, 138 December 2, 2020. Full-text: https://doi.org/10.1038/s41420-020-00375-y A retrospective...
Blog 2 Dezember Cao A, Rohaut B, Guennec LL, et al. Severe COVID-19-related encephalitis can respond to immunotherapy. Brain December 2, 2020. Full-text: https://doi.org/10.1093/brain/awaa337 See title (“can” respond). The authors report a case series...
Blog 2 Dezember Perez S, Innes GK, Walters MS, et al. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey,...
The daily Top 10 – every day the best papers published in the best medical and scientific journals. By Christian Hoffmann & Bernd S. Kamps. Copy-editor: Rob Camp. 30 November Epidemiology Vos ERA,...
29 November Trieu MC, Bansal A, Madsen A, et al. SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. J Infect Dis. 2020 Nov...
Blog 29 November Knoouhuizen SA, Aday A, Lee WM. Ketamine‐Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient with COVID‐19. Hepatology 23 November 2020. Full-text: https://doi.org/10.1002/hep.31650 Prior reports of recreational ketamine abuse have been...
Blog 2 Dezember Lee EH, Kepler KL, Geevarughese A, et al. Race/Ethnicity Among Children With COVID-19–Associated Multisystem Inflammatory Syndrome. JAMA Netw Open November 30, 2020;3(11):e2030280. Full-text: https://doi.org/10.1001/jamanetworkopen.2020.30280 Distribution of race/ethnicity among 223 MIS-C cases...
29 November Vogel G, Couzin-Frankel J. Grade: incomplete. Science 27 November 2020: Vol. 370, Issue 6520, pp. 1023-1027. Full-text: https://doi.org/10.1126/science.370.6520.1023 Schools around the world are again the site of a large, and largely uncontrolled,...
Blog 24 November Yu B, Li C, Sun Y, et al. Insulin treatment is associated with increased mortality in patients with COVID-19. Cell Metabolism November 23, 2020. Full-text: https://doi.org/10.1016/j.cmet.2020.11.014 Oops! In this retrospective study...
13 November Rubin EJ, Baden LR, Morrissey S. An Update from Operation Warp Speed. Audio interview (28:20). N Engl J Med 2020; 383: e127. Access: https://doi.org/%2010.1056/NEJMe2033111 The editors discuss the pace of discovery in...
5th International Edition | 7 November | Finally, after five months, we have published the next edition of COVID Reference – The COVID Textbook (462 pages; we apologize for the delay). We will keep...
| 6 November | An early inhalation of nanobodies – the future treatment? VHH antibodies or nanobodies (Nbs) are minimal, monomeric antigen-binding domains derived from camelid single-chain antibodies. Unlike IgG antibodies, Nbs are small,...
| 5 November 2020 | The estimated risk of infection from touching a contaminated surface was less than 5 in 10,000 in a study by Amy Pickering, Abigail Harvey and colleagues. From April to...
| 3 November 2020 | Singapore’s comprehensive approach to COVID-19 control, much of which was prepared following the 2003 SARS epidemic, is likely to have contributed to the low secondary attack rate among household...
| 2 November 2020 | In this multicenter cohort study (7 hospitals in New York City and Milan) the authors analyzed hospitalized COVID-19 patients who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during...
Is the low case ratality rate of COVID-19 in Hong Kong deceptive? During the first weeks of the SARS-CoV-2 pandemic, a very low CFR of only 0.4% has been reported (Lui GC 2000). Is...
| 31 October | Important study (because prospective). After enrollment, 101 index patients and 191 household members were trained remotely by study staff members to complete symptom diaries and obtain self-collected specimens, nasal swabs...
Purgatorio | 31 de octubre | Si lees español, lee Los médicos en las UCI: “Aún no es el infierno, pero sí el purgatorio”. El País 2020, published 31 October | Una cuarta parte...
| Treatment | 31 October 2020 | Let’s face reality: at the beginning of the second pandemic wave, we have some steroids which have been shown to reduce mortality in patients with severe COVID-19;...
SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality. This is the result of a study by Jonathan Li, Jesse Fajnzylber and colleagues who report SARS-CoV-2 respiratory tract, plasma, and...
France lockdown | 28 October | The dramatic second COVID-19 wave in France has lead Emmanuel Macron to announce a new lockdown in the country. The November lockdown which is due to last at...
The country-specific crude case fatality rates (CFR), the percentage of COVID-19-associated deaths among confirmed SARS-CoV-2 infections, have been the subject of much speculation. There are still striking differences between countries. According to worldometer.com accessed...
Herd immunity has recently been discussed as a desirable result of wide-scale vaccination programs. (High levels of vaccination-induced immunity in the population benefits those who can’t receive or sufficiently respond to a vaccine, such...
Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19. This is the result of a randomized, double-blind, placebo-controlled trial involving SARS-CoV-2 patients with hyperinflammatory states and at...
Could saliva be the future of mass screening? In his comment on the paper by Isao Yokota et al. we presented on September 29, Lorenzo Azzi highlights the potential merits of saliva: it can...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.